MENINGIOMA
Clinical trials for MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new MENINGIOMA trials appear
Sign up with your email to follow new studies for MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Boron therapy shows promise for tough brain tumors
Disease control CompletedThis completed phase I/II trial tested a treatment called boron neutron capture therapy (BNCT) using a boron-based drug (B10 L-BPA) in 10 adults with recurrent meningioma, a type of brain tumor. The goal was to see if the treatment is safe and can shrink tumors or stop them from …
Matched conditions: MENINGIOMA
Phase: PHASE1, PHASE2 • Sponsor: Heron Neutron Medical Corp. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Experimental combo targets Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested a combination of two drugs—177Lu-DOTA-TATE (a radioactive therapy) and olaparib (a PARP inhibitor)—in 18 people with certain cancers like neuroendocrine tumors, thymoma, or mesothelioma that have a specific marker (somatostatin receptor). The goal wa…
Matched conditions: MENINGIOMA
Phase: PHASE1 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Glowing dye could help surgeons spot hidden brain tumor cells
Diagnosis CompletedThis phase 3 trial tested a drug called Gleolan in 108 adults with meningioma (a type of brain tumor). Patients took a single oral dose before surgery. The drug makes tumor tissue glow under special light, helping surgeons see and remove more of the tumor. The study checked if th…
Matched conditions: MENINGIOMA
Phase: PHASE3 • Sponsor: NX Development Corp • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
Less contrast, same clarity: new MRI method could reduce gadolinium exposure
Diagnosis CompletedThis study looked at whether using a much lower dose of gadolinium (a contrast dye) in MRI scans can still find meningiomas (a type of brain tumor) as well as the standard full dose. Over 500 adults getting a brain MRI for screening or follow-up took part. The goal is to reduce t…
Matched conditions: MENINGIOMA
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
New Gadolinium-Free MRI dye shows promise for brain scans
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, made with manganese instead of gadolinium, in 18 adults with known brain lesions (like tumors or multiple sclerosis). The goal was to see if it is safe and can detect lesions as well as current gadolinium-based dyes. Each…
Matched conditions: MENINGIOMA
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Brain tumor insomnia targeted by CBT in new pilot study
Symptom relief CompletedThis study tested a type of talk therapy called Cognitive Behavioral Therapy for Insomnia (CBT-I) in 70 people with brain tumors who also had trouble sleeping. The therapy involved six weekly group sessions delivered online. The main goal was to see if the approach was practical …
Matched conditions: MENINGIOMA
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Scientists hunt for biomarkers to personalize proton beam cancer therapy
Knowledge-focused CompletedThis completed study enrolled 84 people with brain tumors, meningioma, or high-grade sarcoma who received proton beam therapy. Researchers analyzed tumor and blood samples to find biomarkers that might predict how well the cancer responds to treatment. The goal is to eventually h…
Matched conditions: MENINGIOMA
Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a Child's tumor DNA guide better cancer treatment?
Knowledge-focused CompletedThis study tested whether analyzing the DNA and RNA of a child's tumor could help doctors choose personalized treatments. It included 186 children with relapsed or hard-to-treat cancers like neuroblastoma and brain tumors. The goal was to see if this approach was feasible and saf…
Matched conditions: MENINGIOMA
Phase: NA • Sponsor: Giselle Sholler • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC